<table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="tbl1" position="float"><object-id pub-id-type="doi">10.7554/eLife.02848.006</object-id><label>Table 1.</label><caption><p>Structure-activity relationship analysis demonstrates specificity of inhibition</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.02848.006">http://dx.doi.org/10.7554/eLife.02848.006</ext-link></p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="5">A</th></tr><tr><th>Compound name</th><th>CID</th><th>Screen score</th><th>FP K<sub>i, app</sub> (&#181;M)</th><th>F&#8211;EMSA K<sub>i, app</sub> (&#181;M)</th></tr></thead><tbody><tr><td>Chembridge 7409829</td><td align="char" char=".">28425</td><td align="char" char=".">0.045</td><td align="char" char="plusmn">15 &#177; 2.8</td><td align="char" char="plusmn">54 &#177; 22</td></tr><tr><td>Aurintricarboxylic Acid (ATA)</td><td align="char" char=".">2259</td><td align="char" char=".">0.053</td><td align="char" char="plusmn">0.23 &#177; 0.03</td><td align="char" char="plusmn">1.5 &#177; 0.14</td></tr><tr><td>GW7647</td><td align="char" char=".">3397731</td><td align="char" char=".">&#8722;0.028</td><td align="char" char="plusmn">6.5 &#177; 0.4</td><td align="char" char="plusmn">21 &#177; 0.8</td></tr><tr><td>Oleic Acid</td><td align="char" char=".">445639</td><td align="char" char=".">&#8722;0.005</td><td align="char" char="plusmn">1.2 &#177; 0.4</td><td align="char" char="plusmn">1.4 &#177; 0.7</td></tr></tbody></table><table frame="hsides" rules="groups"><thead><tr><th colspan="5">B</th></tr><tr><th>Compound name</th><th>Structure</th><th>Code</th><th>FP K<sub>i, app</sub> (&#181;M)</th><th>F&#8211;EMSA K<sub>i, app</sub> (&#181;M)</th></tr></thead><tbody><tr><td>Oleic acid</td><td><inline-graphic xlink:href="elife-02848-inf1-v2"/></td><td>18:1 &#969;-9</td><td>1.2 &#177; 0.4</td><td>1.4 &#177; 0.7</td></tr><tr><td>Eicosenoic acid</td><td><inline-graphic xlink:href="elife-02848-inf2-v2"/></td><td>20:1 &#969;-9</td><td>1.2 &#177; 0.4</td><td>1.7 &#177; 0.6</td></tr><tr><td>Erucic acid</td><td><inline-graphic xlink:href="elife-02848-inf3-v2"/></td><td>22:1 &#969;-9</td><td>0.64 &#177; 0.2</td><td>0.82 &#177; 0.03</td></tr><tr><td>Nervonic acid</td><td><inline-graphic xlink:href="elife-02848-inf4-v2"/></td><td>24:1 &#969;-9</td><td>47 &#177; 30</td><td>23 &#177; 8</td></tr><tr><td>Palmitoleic acid</td><td><inline-graphic xlink:href="elife-02848-inf5-v2"/></td><td>16:1 &#969;-7</td><td>5.3 &#177; 0.5</td><td>13 &#177; 0.9</td></tr><tr><td>Linoleic acid</td><td><inline-graphic xlink:href="elife-02848-inf6-v2"/></td><td>18:2 &#969;-6, 9</td><td>2.2 &#177; 0.2</td><td>1.2 &#177; 0.03</td></tr><tr><td>Arachidonic acid</td><td><inline-graphic xlink:href="elife-02848-inf7-v2"/></td><td>20:4 &#969;-6, 9, 12, 15</td><td>3.0 &#177; 0.2</td><td>1.1 &#177; 0.3</td></tr><tr><td>Oleoyl-CoA</td><td><inline-graphic xlink:href="elife-02848-inf8-v2"/></td><td>(18:1 &#969;-9)</td><td>8.1 &#177; 0.3</td><td>4.0 &#177; 0.2</td></tr><tr><td>Erucyl-CoA</td><td><inline-graphic xlink:href="elife-02848-inf9-v2"/></td><td>(18:1 &#969;-9)</td><td>4.1 &#177; 0.9</td><td>0.62 &#177; 0.2</td></tr><tr><td>Ricinoleic acid</td><td><inline-graphic xlink:href="elife-02848-inf10-v2"/></td><td>(18:1 &#969;-9)</td><td>No inh.</td><td>18 &#177; 9</td></tr><tr><td>Oleamide</td><td><inline-graphic xlink:href="elife-02848-inf11-v2"/></td><td>(18:1 &#969;-9)</td><td>No inh.</td><td>No inh.</td></tr><tr><td>Ethyl oleate</td><td><inline-graphic xlink:href="elife-02848-inf12-v2"/></td><td>(18:1 &#969;-9)</td><td>No inh.</td><td>No inh.</td></tr><tr><td>4-Methylumbelliferyl Oleate</td><td><inline-graphic xlink:href="elife-02848-inf13-v2"/></td><td>(18:1 &#969;-9)</td><td>No inh.</td><td>No inh.</td></tr><tr><td>Elaidic acid</td><td><inline-graphic xlink:href="elife-02848-inf14-v2"/></td><td>18:1(trans)</td><td>No inh.</td><td>No inh.</td></tr><tr><td>Stearic acid</td><td><inline-graphic xlink:href="elife-02848-inf15-v2"/></td><td>18:0</td><td>No inh.</td><td>No inh.</td></tr><tr><td>Palmitic acid</td><td><inline-graphic xlink:href="elife-02848-inf16-v2"/></td><td>16:0</td><td>No inh.</td><td>No inh.</td></tr><tr><td>Myristic acid</td><td><inline-graphic xlink:href="elife-02848-inf17-v2"/></td><td>14:0</td><td>No inh.</td><td>No inh.</td></tr></tbody></table><table-wrap-foot><fn><p>(<bold>A</bold>) Small molecule screen hits. Compound ID (CID) refers to each compound's LOPAC identification number. Screen scores were calculated by normalizing the polarization value of each compound to the no protein and no compound controls, as described in the supplemental methods. After the screen was complete, compounds that scored as hits were confirmed by FP and F&#8211;EMSA dose response experiments. Apparent inhibition constants (K<sub>i, app</sub>) are the average and standard deviation of at least three independent experiments. (<bold>B</bold>) The code = carbon number:number of double bonds, followed by the position of the double bonds from the aliphatic end of the fatty acid. Where a fatty acid is modified, the parental fatty acid numerical code is given in parentheses for comparison purposes. FP and F-EMSA dose response results are reported as the average and standard deviation of at least three independent experiments.</p></fn></table-wrap-foot></table-wrap>